- Oliver Hesse, Head of Biotec Data Science & Digitalization, Bayer Pharmaceuticals
- Dr. Anastasia Christianson, VP of R&D Business Technology, Janssen Pharmaceuticals
- Dr. Timothy Gardner, Founder and CEO, Riffyn
About this presentation:
“Will COVID-19 Produce a New Normal in R&D -- Faster, More Decentralized, More Digitized? In this webinar, speakers discussed how innovations in scientific workflows, digitization, and process technology are shaping R&D.
This webinar was originally aired on June 17, 2020 on the BIO-IT World Online Learning community.